Integral Health Asset Management, LLC
Position in NBIX — Neurocrine Biosciences Inc
CIK 1773206
New York, NY
Position in NBIX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$19,761,000
-$1,513,500 QoQ
Shares Held
150,000
0.0% QoQ
Ownership
0.149%
of shares outstanding
% of Portfolio
1.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
13 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Integral Health Asset Management, LLC holds $42,403,750 across 3 Drug Manufacturers - Specialty & Generic names. NBIX ranks #1 (46.6% of the industry book) .
All Filings in NBIX
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $19,761,000 | 150,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $21,274,500 | 150,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $21,057,000 | 150,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $18,853,500 | 150,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $16,590,000 | 150,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $21,840,000 | 160,000 | Shares | Sole | 2025-02-14 | |
| 2024-06-30 | $9,636,900 | 70,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $20,688,000 | 150,000 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $11,858,400 | 90,000 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $9,562,500 | 85,000 | Shares | Sole | 2023-11-14 | |
| 2022-09-30 | $9,558,900 | 90,000 | Shares | Sole | 2022-11-14 | |
| 2022-03-31 | $3,281,250 | 35,000 | Shares | Sole | 2022-05-12 | |
| 2020-06-30 | $2,440,000 | 20,000 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||